Target intelligence / Profile preview

Ubiquitin carboxyl-terminal hydrolase 24

Molecular classification
Enzyme, Deubiquitinase, Ubiquitin carboxyl-terminal hydrolase family
01

Overview

Ubiquitin carboxyl-terminal hydrolase 24 is an enzymatic member of the deubiquitinase family involved in the removal of ubiquitin moieties from substrate proteins, thus regulating their stability, turnover, and fate. This enzyme is understood to play critical roles in cell survival and protein homeostasis, acting within the ubiquitin-proteasome system to maintain proper cellular function[7]. Like other UCH family members, its enzymatic activity may influence key biological processes such as cell proliferation, apoptosis, and response to cellular stress or damage[1][7]. Although direct pharmacological targeting is not well developed, modulation of this enzyme is of interest in cancer biology and potentially in neurodegenerative and other diseases linked to disturbed protein degradation.

Other names
Deubiquitinating enzyme 24
02

Mechanism of action

Drugs targeting deubiquitinases usually act via: - Inhibition of catalytic activity affecting removal of ubiquitin from substrate proteins - Modulation of cell survival by altering ubiquitin-dependent protein degradation and signaling[7]

03

Biological functions

Protein degradationRegulation of protein stabilityCell survivalUbiquitin-proteasome system involvement
04

Disease associations

CancerNeurodegenerationCell death-related processes
05

Safety considerations

Potential broad effects on protein homeostasisToxicity from altered cell survival or apoptosisOff-target effects due to family similarity
06

Biomarkers

Altered deubiquitinase activity

Beyond the preview

Go deeper on Ubiquitin carboxyl-terminal hydrolase 24.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin carboxyl-terminal hydrolase 24.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call